Ligand Pharmaceuticals
LGND
#4061
Rank
C$3.23 B
Marketcap
$170.97
Share price
1.11%
Change (1 day)
124.54%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2023 (TTM): $2.11

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $2.20. In 2022 the company made an earnings per share (EPS) of -$2.77 a decrease over its 2021 EPS that were of $4.85.

EPS history for Ligand Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.11-176.26%
2022-$2.77-157.23%
2021$4.85-2571.43%
2020-$0.20-100.46%
2019$42.87353.48%
2018$9.451025%
2017$0.84-700%
2016-$0.14-100.87%
2015$16.191859.32%
2014$0.835.36%
2013$0.788.0704505322479E+18%
2012$0.0000000000-100%
2011$0.69-194.23%
2010-$0.73548.38%
2009-$0.11-98.7%
2008-$8.65-136.52%
2007$23.70-787.8%
2006-$3.45-14.58%
2005-$4.03-21.31%
2004-$5.13-55.15%
2003-$11.4381.33%
2002-$6.302.74%
2001-$6.13-45.93%
2000-$11.34-14.56%
1999-$13.28-45.52%
1998-$24.37-3.97%
1997-$25.38132.31%
1996-$10.92

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$19.82 801.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.50-122.93%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.90 122.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
$2.55 16.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.60 18.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.60 245.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.56 152.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.17 226.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$19.73 797.15%๐Ÿ‡บ๐Ÿ‡ธ USA